Kidney Stone Calculator

Estimate spontaneous passage rates by stone size and location, treatment options, prevention strategies, and 24-hour urine interpretation for kidney stones.

โš ๏ธ Medical Disclaimer: Stone management depends on complete clinical evaluation including imaging. Fever with a stone, anuria, or uncontrolled pain and vomiting are urgent scenarios that need prompt medical assessment.
24-Hour Urine Results (optional)
Spontaneous Passage Rate
60%
For a 5mm stone in the distal ureter. Passage rate decreases with increasing size and more proximal location.
Expected Passage Time
2-4 weeks (with MET)
Time to passage with adequate hydration and medical expulsive therapy (tamsulosin). May vary significantly.
Typical Management Context
Smaller ureteral stones often start in an observation-focused pathway, with expulsive-therapy discussion varying by clinician and local practice.
This is size-and-location framing only. The real pathway still depends on symptoms, anatomy, infection status, renal function, and clinician review.
Stone Composition
Most common (70-80%). Often mixed with calcium phosphate. Associated with hypercalciuria, hyperoxaluria.
Analysis based on calcium oxalate composition. Send all passed/extracted stones for formal analysis.
Recurrence Risk
30-50% risk of recurrence within 5 years without prevention
The page uses broad recurrence framing rather than patient-specific outcome prediction.
Prevention Considerations
Increase fluid intake to 2.5-3L/day; Moderate calcium intake (1000-1200mg/day) โ€” do NOT avoid dairy; Reduce oxalate-rich foods (spinach, nuts, chocolate, rhubarb); Increase citrate (lemon water, citrus fruits); Limit sodium to <2300 mg/day; Moderate animal protein
These are broad stone-prevention themes that should be individualized to stone type and metabolic review.

Passage Rates by Stone Size

SizeDistal UreterProximal UreterExpected Time
โ‰ค 2mm95%80%1-7 days
3-4mm76%50%1-2 weeks
5-6mm60%25%2-4 weeks
7-8mm35%8%Unlikely
> 8mm< 10%< 5%Intervention needed
Planning notes, formulas, and examples

About the Kidney Stone Calculator

The Kidney Stone Calculator estimates spontaneous passage probability, expected passage time, treatment direction, and prevention steps based on stone size, location, and composition. Stone management often starts with the question of whether observation and medical expulsive therapy are reasonable or whether procedural treatment is more likely to be needed.

Stone size and location matter most in the acute setting: small distal ureteral stones pass more often than larger or more proximal stones. This calculator maps those inputs to a practical management summary and can also interpret 24-hour urine metabolic data when prevention planning is needed.

For recurrent stone formers, the page can also highlight common prevention themes such as fluid intake, sodium reduction, citrate, and composition-specific diet changes.

When This Page Helps

Stone size, location, and composition can change the expected course quite a bit, so a quick estimate is useful when deciding whether observation is reasonable or whether earlier urologic treatment should be discussed. The same page also helps frame prevention work after the acute episode passes.

How to Use the Inputs

  1. Enter the stone size in millimeters from CT imaging (largest dimension)
  2. Select stone location โ€” distal ureter has the highest passage rates
  3. Choose the stone type if composition is known from prior analysis
  4. Indicate whether this is a first or recurrent stone
  5. Optionally enter 24-hour urine metabolic results for detailed prevention guidance
  6. Review passage probability, treatment options, and customized diet/medication recommendations
Formula used
Spontaneous passage rates derived from meta-analyses: distal ureter <4mm: 76-95%, 4-6mm: 60%, >6mm: 35%. Proximal ureter rates are 20-30% lower. Medical expulsive therapy (tamsulosin) increases passage rates by ~30% for stones 5-10mm.

Example Calculation

Result: 60% passage rate, expected 2-4 weeks with MET

A 5mm distal ureteral calcium oxalate stone has approximately 60% chance of spontaneous passage. Medical expulsive therapy with tamsulosin 0.4 mg daily is often discussed alongside hydration and pain-control planning. NSAIDs (ketorolac, ibuprofen) for pain control.

Tips & Best Practices

  • Strain all urine through a fine mesh strainer โ€” captured stones should be sent for formal composition analysis
  • NSAIDs (ibuprofen 600mg, ketorolac) are more effective than opioids for renal colic pain
  • Do NOT restrict dietary calcium โ€” low calcium diets paradoxically increase oxalate absorption and stone risk
  • Lemon water (4 oz fresh lemon juice daily) is a natural source of citrate for stone prevention
  • Reduce sodium intake to <2300 mg/day โ€” excess sodium increases urinary calcium excretion
  • For recurrent stone formers, a 24-hour urine collection (Litholink, 24/7 Kidney Stone Lab) is essential for targeted prevention

Stone Types and Their Management

**Calcium Oxalate (70-80%)**: The most common stone type, often with calcium phosphate core. Risk factors include hypercalciuria, hyperoxaluria, hypocitraturia, and low urine volume. Dietary management focuses on adequate calcium intake (1000-1200 mg/day โ€” paradoxically, adequate calcium binds dietary oxalate in the gut), reduced sodium and animal protein, increased citrate, and avoidance of high-oxalate foods (spinach, nuts, chocolate). Thiazide diuretics reduce urinary calcium; potassium citrate increases urinary citrate.

**Uric Acid (5-10%)**: The only dissolution-eligible stone. Form in acidic urine (pH < 5.5) and are radiolucent on X-ray. Management: alkalinize urine to pH 6.0-6.5 with potassium citrate (20-30 mEq TID), increase fluids, reduce purine-rich foods. Allopurinol for hyperuricemia. Complete dissolution may take 2-6 months.

**Struvite (5-15%)**: Caused by urease-producing bacteria that split urea into ammonia, raising urine pH and creating magnesium ammonium phosphate crystals. Can form large "staghorn" calculi filling the renal pelvis. Treatment requires surgical removal plus targeted antibiotics. Acetohydroxamic acid (AHA) inhibits urease but has significant side effects.

**Cystine (1-2%)**: Autosomal recessive cystinuria causing excessive urinary cystine. Requires lifelong management: very high fluid intake (>3L/day, including nighttime waking), urine alkalinization to pH 7.0-7.5, sodium restriction, and potentially tiopronin or D-penicillamine for refractory cases.

ESWL vs. Ureteroscopy vs. PCNL

The three main surgical options for kidney stones differ in their indications and effectiveness:

**ESWL** (Extracorporeal Shock Wave Lithotripsy): Non-invasive, outpatient. Best for renal stones โ‰ค20mm and proximal ureteral stones. Stone-free rates 50-70%. Less effective for lower pole stones, hard stones (calcium oxalate monohydrate, cystine), obese patients, and stones >15mm. No incisions required.

**Ureteroscopy (URS)**: Flexible or semi-rigid scope with laser lithotripsy. Stone-free rates 80-95% for ureteral stones, 70-85% for renal stones. Can treat stones in any location. Requires anesthesia and possible stent placement. Gold standard for mid/distal ureteral stones.

**PCNL** (Percutaneous Nephrolithotomy): Most invasive but most effective for large renal stones (>20mm). Stone-free rates 85-95%. Requires percutaneous renal access, hospitalization, and carries higher complication risk. Indicated for staghorn calculi and large stone burdens.

Sources & Methodology

Last updated:

Methodology

This worksheet applies published stone-size and stone-location passage ranges, plus common metabolic-prevention themes, to summarize acute and preventive kidney-stone context. It is a planning aid, not a urology treatment order or an emergency pathway.

Sources

Frequently Asked Questions

  • Stones โ‰ค4mm in the distal ureter pass spontaneously 76-95% of the time. Stones 5-6mm have about 60% passage rates with medical expulsive therapy. Stones >6mm in the ureter and >10mm in the kidney typically require intervention.